Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model

The immunity acquired after natural infection or vaccinations against SARS-CoV-2 tend to wane with time. Here, we compared the protective efficacy of COVAXIN® following two- and three-dose immunizations against the Delta variant and also studied the efficacy of COVAXIN® against Omicron variants in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yadav, Pragya D., Mohandas, Sreelekshmy, Shete, Anita, Sapkal, Gajanan, Deshpande, Gururaj, Kumar, Abhimanyu, Wakchaure, Kundan, Dighe, Hitesh, Jain, Rajlaxmi, Ganneru, Brunda, Yemul, Jyoti, Gawande, Pranita, Vadrevu, Krishna Mohan, Abraham, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493142/
https://www.ncbi.nlm.nih.gov/pubmed/36164480
http://dx.doi.org/10.1016/j.isci.2022.105178

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493142/
https://www.ncbi.nlm.nih.gov/pubmed/36164480
http://dx.doi.org/10.1016/j.isci.2022.105178

Ejemplares similares